Engaging United States Black Communities in HIV Pre-exposure Prophylaxis: Analysis of a PrEP Engagement Cascade

被引:25
作者
Kwakwa, Helena Akua [1 ]
Bessias, Sophia [1 ]
Sturgis, Donielle [1 ]
Walton, Gina [1 ]
Wahome, Rahab [2 ]
Gaye, Oumar [1 ]
Jackson, Mayla [1 ]
机构
[1] Philadelphia Dept Publ Hlth, Div Ambulatory Hlth Serv, 500 South Broad St, Philadelphia, PA 19146 USA
[2] AIDS Care Grp, 907 Chester Pike, Sharon Hill, PA 19079 USA
关键词
HIV; PrEP; Engagement; Cascade; Black; MEN; TRIAL; WOMEN; RISK; SEX; MSM;
D O I
10.1016/j.jnma.2017.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Purpose: National PrEP utilization analyses show US non-Hispanic Blacks accessing PrEP at disproportionately low rates given the higher HIV prevalence among Blacks, and in comparison to utilization by non-Hispanic Whites. Women also are underrepresented among PrEP utilizers, especially Black women. We examine the process of accessing PrEP for a majority Black population in an urban community health center setting. Methods: In the Philadelphia city health centers, patients referred for PrEP were followed through six steps of accessing PrEP: referral, patient contact by a PrEP team, maintained interest by patients, scheduling of screening appointments, attending screening appointments, and initiating PrEP. Chi-squared tests were performed at each stage to identify gender differences in drop-off at each step. Results: Between August 2014 and December 2015, 14% of 785 patients referred for PrEP initiated. Women constituted 37.8% of referrals. A smaller majority of Blacks initiated (84.6% of females, 69.5% of males) than were referred (94.5% of females, 88.1% of males). Prior knowledge of PrEP was associated with screening (68% of those with prior knowledge screened, compared with 29.6% of those without prior knowledge,X2 p<0.0001). Higher initiation: referral ratios were noted for self-referrals, and for those referred by clinicians, peers and partners. Conclusions: In a diverse cohort in a community health center setting, myriad barriers resulted in a 14% initiation rate for persons at elevated risk for HIV who were referred for PrEP. These barriers led to disproportionately fewer non-Hispanic Blacks and women initiating PrEP. Efforts to better engage Blacks and women in PrEP care are urgently needed, and may include better dissemination of PrEP-related information in Black communities and to women, and training of clinicians serving Black and female populations to improve competency in provision of PrEP care.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 28 条
[1]  
[Anonymous], 2012, FDA APPR 1 DRUG RED
[2]  
[Anonymous], 2015, HIV Surveillance Report, V27
[3]  
Aragon T.J., 2012, EPITOOLS EPIDEMIOLOG
[4]  
Bush S, 2016, ASM MICR 2016 ICAAC
[5]  
Bush S, 10 INT C HIV TREAT P
[6]   Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial [J].
Choopanya, Kachit ;
Martin, Michael ;
Suntharasamai, Pravan ;
Sangkum, Udomsak ;
Mock, Philip A. ;
Leethochawalit, Manoj ;
Chiamwongpaet, Sithisat ;
Kitisin, Praphan ;
Natrujirote, Pitinan ;
Kittimunkong, Somyot ;
Chuachoowong, Rutt ;
Gvetadze, Roman J. ;
McNicholl, Janet M. ;
Paxton, Lynn A. ;
Curlin, Marcel E. ;
Hendrix, Craig W. ;
Vanichseni, Suphak .
LANCET, 2013, 381 (9883) :2083-2090
[7]  
Delaney KP, 2016, 23 C RETR OPP INF CR
[8]   Minimal Awareness and Stalled Uptake of Pre-Exposure Prophylaxis (PrEP) Among at Risk, HIV-Negative, Black Men Who Have Sex with Men [J].
Eaton, Lisa A. ;
Driffin, Daniel D. ;
Bauermeister, Jose ;
Smith, Harlan ;
Conway-Washington, Christopher .
AIDS PATIENT CARE AND STDS, 2015, 29 (08) :423-430
[9]   The Right People, Right Places, and Right Practices: Disparities in PrEP Access Among African American Men, Women, and MSM in the Deep South [J].
Elopre, Latesha ;
Kudroff, Kachina ;
Westfall, Andrew O. ;
Overton, Edgar T. ;
Mugavero, Michael J. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 (01) :56-59
[10]  
Gibson S, 2016, 21 INT AIDS C AIDS 2